An announcement from Australian Clinical Labs Ltd ( (AU:ACL) ) is now available.
Australian Clinical Labs Limited has announced a change in its substantial holders, with Wilson Asset Management Group acquiring a significant interest in the company. This acquisition indicates a shift in the company’s shareholder structure, potentially impacting its strategic direction and market positioning.
More about Australian Clinical Labs Ltd
YTD Price Performance: -9.88%
Average Trading Volume: 595,964
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$621.8M
Find detailed analytics on ACL stock on TipRanks’ Stock Analysis page.